These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 36430144)
1. What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review. Bonnechère B; Amin N; van Duijn C Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430144 [TBL] [Abstract][Full Text] [Related]
2. Gut bacterial profiles in Parkinson's disease: A systematic review. Li Z; Liang H; Hu Y; Lu L; Zheng C; Fan Y; Wu B; Zou T; Luo X; Zhang X; Zeng Y; Liu Z; Zhou Z; Yue Z; Ren Y; Li Z; Su Q; Xu P CNS Neurosci Ther; 2023 Jan; 29(1):140-157. PubMed ID: 36284437 [TBL] [Abstract][Full Text] [Related]
3. Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases. Gerhardt S; Mohajeri MH Nutrients; 2018 Jun; 10(6):. PubMed ID: 29857583 [TBL] [Abstract][Full Text] [Related]
4. The Role of Gut Microbiota in Various Neurological and Psychiatric Disorders-An Evidence Mapping Based on Quantified Evidence. Zang Y; Lai X; Li C; Ding D; Wang Y; Zhu Y Mediators Inflamm; 2023; 2023():5127157. PubMed ID: 36816743 [TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review. Heravi FS; Naseri K; Hu H Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892440 [TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients. Proano AC; Viteri JA; Orozco EN; Calle MA; Costa SC; Reyes DV; German-Montenegro M; Moncayo DF; Tobar AC; Moncayo JA Neurol Int; 2023 Jun; 15(2):750-763. PubMed ID: 37368331 [TBL] [Abstract][Full Text] [Related]
7. Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review. Ordoñez-Rodriguez A; Roman P; Rueda-Ruzafa L; Campos-Rios A; Cardona D Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901634 [TBL] [Abstract][Full Text] [Related]
8. The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials. Schepici G; Silvestro S; Bramanti P; Mazzon E Cell Transplant; 2019 Dec; 28(12):1507-1527. PubMed ID: 31512505 [TBL] [Abstract][Full Text] [Related]
9. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis. Fang X Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230 [TBL] [Abstract][Full Text] [Related]
10. Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson's disease with Buyang Huanwu decoction. Hu J; Li P; Zhao H; Ji P; Yang Y; Ma J; Zhao X J Ethnopharmacol; 2024 Jan; 318(Pt A):116893. PubMed ID: 37423520 [TBL] [Abstract][Full Text] [Related]
11. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis. Li F; Ye J; Shao C; Zhong B Lipids Health Dis; 2021 Feb; 20(1):22. PubMed ID: 33637088 [TBL] [Abstract][Full Text] [Related]
12. [The gut microbiome in Parkinson's disease]. Bedarf JR; Hildebrand F; Goeser F; Bork P; Wüllner U Nervenarzt; 2019 Feb; 90(2):160-166. PubMed ID: 30171304 [TBL] [Abstract][Full Text] [Related]
13. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models. Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385 [TBL] [Abstract][Full Text] [Related]
14. Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan. Kaiyrlykyzy A; Kozhakhmetov S; Babenko D; Zholdasbekova G; Alzhanova D; Olzhayev F; Baibulatova A; Kushugulova AR; Askarova S Sci Rep; 2022 Sep; 12(1):15115. PubMed ID: 36068280 [TBL] [Abstract][Full Text] [Related]
15. The multiple sclerosis gut microbiota: A systematic review. Mirza A; Forbes JD; Zhu F; Bernstein CN; Van Domselaar G; Graham M; Waubant E; Tremlett H Mult Scler Relat Disord; 2020 Jan; 37():101427. PubMed ID: 32172998 [TBL] [Abstract][Full Text] [Related]
16. Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study. Ning J; Huang SY; Chen SD; Zhang YR; Huang YY; Yu JT J Alzheimers Dis; 2022; 87(1):211-222. PubMed ID: 35275534 [TBL] [Abstract][Full Text] [Related]
17. Role of the gut microbiota in the development of various neurological diseases. Castillo-Álvarez F; Marzo-Sola ME Neurologia (Engl Ed); 2022; 37(6):492-498. PubMed ID: 35779869 [TBL] [Abstract][Full Text] [Related]
18. [Investigation of the Relationship Between Akkermansia Genomic Diversity in Gut Microbiota and Parkinson's Disease Dementia]. Arıkan M; Kahraman Demir T; Yıldız Z; Helvacı Yılmaz N; Şen A; Hanoğlu L; Yıldırım S Mikrobiyol Bul; 2024 Jan; 58(1):13-28. PubMed ID: 38263937 [TBL] [Abstract][Full Text] [Related]
19. The gut microbiome in neurological disorders. Cryan JF; O'Riordan KJ; Sandhu K; Peterson V; Dinan TG Lancet Neurol; 2020 Feb; 19(2):179-194. PubMed ID: 31753762 [TBL] [Abstract][Full Text] [Related]